ArticleBMJ (Clinical research ed.)2024

Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: retrospective cohort study.

Francine Brinkhuis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.